PT95016A - Processo para a preparacao de peptidos terapeuticos - Google Patents

Processo para a preparacao de peptidos terapeuticos

Info

Publication number
PT95016A
PT95016A PT95016A PT9501690A PT95016A PT 95016 A PT95016 A PT 95016A PT 95016 A PT95016 A PT 95016A PT 9501690 A PT9501690 A PT 9501690A PT 95016 A PT95016 A PT 95016A
Authority
PT
Portugal
Prior art keywords
amino acid
acid residue
peptide
active site
preparation
Prior art date
Application number
PT95016A
Other languages
English (en)
Other versions
PT95016B (pt
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of PT95016A publication Critical patent/PT95016A/pt
Publication of PT95016B publication Critical patent/PT95016B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT95016A 1989-08-16 1990-08-16 Processo para a preparacao de peptidos terapeuticos PT95016B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39472789A 1989-08-16 1989-08-16

Publications (2)

Publication Number Publication Date
PT95016A true PT95016A (pt) 1991-04-18
PT95016B PT95016B (pt) 1997-05-28

Family

ID=23560172

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95016A PT95016B (pt) 1989-08-16 1990-08-16 Processo para a preparacao de peptidos terapeuticos

Country Status (15)

Country Link
EP (1) EP0438566B1 (pt)
JP (1) JPH04502922A (pt)
AT (1) ATE143372T1 (pt)
CA (1) CA2039175A1 (pt)
CZ (2) CZ285562B6 (pt)
DD (1) DD298411A5 (pt)
DE (1) DE69028692T2 (pt)
DK (1) DK0438566T3 (pt)
ES (1) ES2094160T3 (pt)
GR (1) GR900100613A (pt)
HU (1) HUT65465A (pt)
IE (1) IE77033B1 (pt)
PT (1) PT95016B (pt)
SK (1) SK402890A3 (pt)
WO (1) WO1991002745A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5410019A (en) * 1987-09-24 1995-04-25 The Administrators Of The Tulane-Educational Fund Therapeutic peptides
FR2680174A1 (fr) * 1991-08-05 1993-02-12 Michelot Robert Nouveaux composes peptidiques, inhibiteurs de l'adsorption du virus hiv sur ses cellules cibles.
EP1082959A1 (en) 1991-09-20 2001-03-14 Glaxo Group Limited NK1 Antagonists for the treatment of depression
US6156725A (en) * 1996-08-16 2000-12-05 National Institute Of Immunology Drug for the treatment of cancer
US6492330B1 (en) 1996-08-16 2002-12-10 National Institute Of Immunology Antiangiogenic drugs
EP0835662B1 (en) * 1996-10-08 2001-11-14 National Institute of Immunology A drug for the treatment of cancer
CA2225185A1 (en) 1997-08-11 1999-02-11 Peter K. Law Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
JP2010516731A (ja) 2007-01-24 2010-05-20 グラクソ グループ リミテッド 2−メトキシ−5−(5−トリフルオロメチル−テトラゾール−1−イル)−ベンジル]−(2s−フェニル−ピペリジン−3s−イル)−アミンを含む医薬組成物
JP5707101B2 (ja) * 2009-11-11 2015-04-22 国立大学法人山口大学 消化器疾患治療剤
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain
WO2023139542A1 (en) * 2022-01-21 2023-07-27 Institut Pasteur De Montevideo Active immunization for reducing osteoarthritic, neuropathic, and cancer pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862114A (en) * 1971-11-22 1975-01-21 Ici Australia Ltd Analogs of substance p
IT1212508B (it) * 1981-12-22 1989-11-22 Anic Spa Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
US4481139A (en) * 1983-04-13 1984-11-06 Board Of Regents, The University Of Texas System Peptide antagonists of substance P
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
NZ229552A (en) * 1988-06-20 1992-06-25 Merrell Dow Pharma Neurokinin a antagonists

Also Published As

Publication number Publication date
CZ285319B6 (cs) 1999-07-14
IE902958A1 (en) 1991-02-27
DD298411A5 (de) 1992-02-20
SK280796B6 (sk) 2000-07-11
PT95016B (pt) 1997-05-28
CZ285562B6 (cs) 1999-09-15
EP0438566B1 (en) 1996-09-25
HUT65465A (en) 1994-06-28
HU906872D0 (en) 1991-07-29
JPH04502922A (ja) 1992-05-28
ATE143372T1 (de) 1996-10-15
WO1991002745A1 (en) 1991-03-07
DE69028692D1 (de) 1996-10-31
EP0438566A4 (en) 1993-03-31
DK0438566T3 (da) 1996-11-11
EP0438566A1 (en) 1991-07-31
IE77033B1 (en) 1997-11-19
ES2094160T3 (es) 1997-01-16
GR900100613A (el) 1991-12-30
SK402890A3 (en) 2000-07-11
CZ402890A3 (cs) 1999-04-14
DE69028692T2 (de) 1997-02-20
CA2039175A1 (en) 1991-02-17

Similar Documents

Publication Publication Date Title
ATE139540T1 (de) Heilmittelpeptide
DK66391A (da) Terapeutisk virksomme peptider
ES2124685T3 (es) Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
ATE113961T1 (de) Therapeutische peptide.
GR900100613A (el) Θεραπευτικά πεπτίδια.
ES2062514T5 (es) Sistema de procesamiento de levadura que comprende un aminoacido cargado negativamente adyacente al sitio de procesamiento.
DK0464140T3 (da) Aktivt adhæsionspeptid
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
ES2194017T3 (es) Proceso para producir polipeptidos, proteinas o peptidos hidrofobos.
BR8907452A (pt) Peptideo e polipeptideo antifilicos,processo e composicao para sua utilizacao
ES2094725T3 (es) Peptidos hcg para la aplicacion en procedimientos de purificacion de anticuerpos.
PT95057A (pt) Processo para a preparacao de peptidos terapeuticos
ATE129744T1 (de) Rekombinantes c-terminal alpha amidatierungsenzym von menschlischem thyroidursprung.
PT93320A (pt) Processo para a preparacao de peptideos terapeuticos
ATE46173T1 (de) Pharmakologisch aktive peptide.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19901226

FG3A Patent granted, date of granting

Effective date: 19970218

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20010831